Skip to content

ResMed RMD Market capitalization

Market capitalization at other companies

Eli Lilly logo
Eli LillyLLY
$821.68B+10.8%
Stryker logo
StrykerSYK
$125.84B-11.4%
Insmed logo
InsmedINSM
$35.25B+155%
GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
$32.48B-12.0%
Boston Scientific logo
Boston ScientificBSX
$93.26B-37.5%
Intuitive Surgical logo
Intuitive SurgicalISRG
$163.73B-7.7%

Other financials

Income statement

See full
Revenue$1.4B+10.8%
Gross profit$891.0M+16.3%
Operating income$499.8M+17.3%
Net income$398.7M+9.2%
EPS (diluted)$2.74+10.5%

Balance sheet

See full
Cash & equivalents$1.7B+78.0%
Total debt$1.1B+29.8%
Total equity$6.5B+17.1%
Total assets$8.8B+16.1%

Cash flow

See full
Operating cash flow$554.1M-4.2%
CapEx$33.7M+61.8%
Free cash flow$520.5M-6.7%

Valuation

See full
Enterprise value$26.8B-2.0%
P/E18×-2.9×
P/S4.9×-0.5×

Profitability

See full
Gross margin61.6%+2.8pp
Operating margin34.2%+2.1pp
Net margin27.4%+1.3pp

Returns & leverage

See full
Return on equity25.2%-0.6pp
Debt / equity0.2×0.0×
Current ratio-0.4×

Where this comes from

Computed from the period-end share price: $32.7B.

The official record: ResMed’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about ResMed's market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ResMed's market capitalization?
ResMed (RMD) reported market capitalization of $32.7B in Q1 2026.
How has ResMed's market capitalization changed year-over-year?
ResMed's market capitalization decreased by 0.5% year-over-year, from $32.88B to $32.7B.
What is the long-term trend for ResMed's market capitalization?
Over 4 years (2021 to 2025), ResMed's market capitalization has grown at a 3.9% compound annual growth rate (CAGR), from $120.15B to $139.84B.
What does market capitalization mean?
What the stock market says the company's equity is worth.
How do you interpret market capitalization?
A size and market-sentiment gauge, not a quality measure — interpret through valuation ratios (P/E, P/S) that relate it to fundamentals.
How does market capitalization compare across companies?
Comparable across companies as a size class; the input to every equity-price valuation multiple.